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Persuasive Interventions for Controversial Cancer 
Screening Recommendations: Testing a Novel Approach 
to Help Patients Make Evidence-Based Decisions
ABSTRACT
PURPOSE We wanted to evaluate novel decision aids designed to help patients 
trust and accept the controversial, evidence-based, US Preventive Services Task 
Force recommendations about prostate cancer screening (from 2012) and mam-
mography screening for women aged 40 to 49 years (from 2009).
METHODS We created recorded vignettes of physician-patient discussions about 
prostate cancer screening and mammography, accompanied by illustrative slides, 
based on principles derived from preceding qualitative work and behavioral sci-
ence literature. We conducted a randomized crossover study with repeated mea-
sures with 27 men aged 50 to 74 years and 35 women aged 40 to 49 years. All 
participants saw a video intervention and a more traditional, paper-based deci-
sion aid intervention in random order. At entry and after seeing each interven-
tion, they were surveyed about screening intentions, perceptions of benefits and 
harm, and decisional conflict.
RESULTS Changes in screening intentions were analyzed without regard to order 
of intervention after an initial analyses showed no evidence of an order effect. 
At baseline, 69% of men and 86% of women reported wanting screening, with 
31% and 6%, respectively, unsure. Mean change on a 3-point, yes, unsure, no 
scale was –0.93 (P = <.001) for men and –0.50 (P = <.001) for women after 
seeing the video interventions vs 0.0 and –0.06 (P = .75) after seeing the print 
interventions. At the study end, 33% of men and 49% of women wanted screen-
ing, and 11% and 20%, respectively, were unsure.
CONCLUSIONS Our novel, persuasive video interventions significantly changed 
the screening intentions of substantial proportions of viewers. Our approach 
needs further testing but may provide a model for helping patients to consider 
and accept evidence-based, counterintuitive recommendations.
Ann Fam Med 2017;15:48-55. https://doi.org/10.1370/afm.1996.
INTRODUCTION
Patients face many medical decisions, and rarely is the evidence about the balance of benefits and harms so unequivocal that it can be assumed all patients would make the same choice if adequately 
informed. Evidence can be complicated and incomplete, and experts’ rec-
ommendations may conflict. Even when there is an evidence-based recom-
mendation for a specific medical decision, patients’ values might lead to a 
different choice. Patients are exposed to social norms, media campaigns, 
and powerful anecdotes regarding testing.1,2 Furthermore, human decision 
making rarely fits the idealized model of a rational, informed process.3,4 
Order of presentation, loss- vs gain-based framing, anchor effects, and 
perceived norms can introduce biases,5-10 and adding information can 
make decisions more difficult.11-14 Shortcuts (heuristics) used to simplify 
decisions often lead to suboptimal choices.15,16 
Thus, the ideal of the informed decision is difficult to achieve in prac-
tice. Charles et al note, “Patient preferences for information do not neces-
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sarily translate into information seeking behavior; nor 
do patients who express preferences for some form 
of shared decision making necessarily act on these in 
the medical encounter.”17 Patients who may not have 
clearly defined values or preferences when asked to 
make a decision may, instead, construct a preference 
to justify their choice.18 A Cochrane review of deci-
sion aids for treatment and screening decisions con-
cluded there was high-quality evidence that decision 
aids could improve knowledge and reduce decisional 
conflict, moderate-quality evidence for helping people 
be more active in making decisions and improving risk 
perception, and low-quality evidence that decision aids 
led to decisions more congruent with patients’ values.19
For preventive services, the focus has been more 
on promoting uptake; for cancer screening tests, the 
typical view is that more is better20,21 given the para-
digm of early detection increasing chances for a cure. 
Few patients understand that some screening tests may 
reduce mortality only modestly or can result in harm.22 
Little research has focused on helping clinicians and 
patients overcome their biases as they present informa-
tion about screening benefits, harms, and uncertainties 
and attempt to make informed and/or shared decisions.23 
The United States Preventive Services Task Force’s 
(USPSTF) recommendation that women aged 40 to 49 
years should make preference-based, individual deci-
sions about mammography highlights the need for the 
development of effective, evidence-based approaches 
to help patients understand why seemingly counter-
intuitive recommendations might make sense.24,25 The 
USPSTF recommendation against screening for pros-
tate cancer with the prostate specific antigen (PSA) 
test26 provides further impetus for such approaches.
Americans receive substantial amounts of low-value 
medical care.27-33 When recommending against care 
can evoke fear and distrust, clinicians are challenged to 
explain why a test or treatment might not be beneficial, 
a challenge compounded by advocacy groups mount-
ing campaigns based on strong, emotional messages 
rather than unbiased evidence.
Some authors have suggested that advocacy should 
be combined with unbiased information, sometimes 
described as informed advocacy34 and beneficent persua-
sion.35 Swindell et al argue that autonomy is not what 
patients value most in their medical decision making, 
nor do most medical decisions resemble the model of 
an informed, autonomous choice.36 Typical medical 
practice more closely resembles an advocacy-based 
process than informed, shared decision making. 
Patients often receive recommendations about 
preference-sensitive choices with little or no discus-
sion, and information is presented in an attempt to 
persuade only if they offer resistance. When strong, 
persuasive messaging is used to advocate for a specific 
choice, patients may need help understanding the 
rationale for making a considered decision.
In this article, we present the results of an initial 
evaluation of interventions developed to help patients 
consider and trust the 2009 USPSTF recommenda-
tions that women in their 40s should make an informed 
choice about mammography and the 2012 recommen-
dation against prostate cancer screening.
METHODS
Overview and Development of Interventions
This study proceeded in 3 phases; phases 1 and 2 
focused on intervention development, and phase 3 
tested intervention effectiveness. This report focuses 
on phase 3, but begins with a brief overview of the first 
2 phases to facilitate understanding of our approach 
and interventions.
Phase 1 involved the conduct and qualitative 
analyses of 6 focus groups (2 in English and 1 in Span-
ish with men aged 50 to 74 years discussing prostate 
cancer screening and the same with women aged 40 to 
49 years discussing mammography). The focus groups 
were conducted to help us understand participants’ 
attitudes toward the cancer screening tests we were 
addressing and factors that might lead patients to trust 
the USPSTF’s recommendations. We concluded that (1) 
discussion needed to begin with information about the 
harms and limited efficacy of the tests because, without 
that information, considering not being screened did 
not make sense; (2) participants were unaware of spe-
cific guidelines; (3) discussion of guideline development 
processes and potential bias had no impact on partici-
pants’ views; (4) participants were not familiar with 
the USPSTF, and attempts to distinguish the USPSTF 
from other groups using bias-prone processes had no 
impact; (5) anecdotal experiences of family and friends 
with cancer screening, diagnosis, and treatment were 
powerful in shaping views about screening, even if the 
anecdotes were not about breast or prostate cancer 
screening; and (6) although no participant asked for 
evidence supporting cancer screening, many wanted 
to know there was good evidence supporting a recom-
mendation to consider not being screened.
In phase 2, we developed sets of 3 videos of 
narrated slide presentations for each topic in both 
English and Spanish. One was framed as a conversa-
tion among friends, including a community health 
worker knowledgeable about the topic, 1 portrayed 
a physician-patient conversation, and the third was a 
presentation by an unseen narrator. The level of detail 
about the evidence varied in the presentations, being 
least in the first, and greatest in the last. We conducted 
C ANCER SCREENING DECISIONS
ANNALS OF FAMILY MEDICINE ✦ WWW.ANNFAMMED.ORG ✦ VOL. 15, NO. 1 ✦ JANUARY/FEBRUARY 2017
50
6 additional focus groups, organized as in phase 1, in 
which participants viewed the presentations in vary-
ing order and discussed their reactions to each. Other 
than 1 group of men disliking the friends’ conversa-
tion format, there were no strong preferences for 
any particular format. Some participants stated that a 
physician-patient conversation seemed more convinc-
ing, and some stated that hearing the complex informa-
tion more than once was helpful.
Based on these findings and the current litera-
ture on persuasion and behavior change, we then 
developed video presentations of slide shows, framed 
as physician-patient conversations (mammography, 
English, at https://youtu.be/6uGy72OCv_Q; mam-
mography, Spanish, at https://youtu.be/rs_pKyFo1DA; 
prostate cancer screening, English, at https://youtu.be/
v5z2Go4ZpO4; prostate cancer screening, Spanish, at 
https://youtu.be/nBce9xJo1lc). Overall flow and content 
are available in the Supplemental Figure, http://annfa-
mmed.org/content/15/1/48/suppl/DC1. Duration of the 
video presentations ranged from about 13½ minutes to 
almost 23 minutes, with Spanish-language and mam-
mography presentations being longer.
Comparator Interventions
We sought unbiased, evidence-based comparators that 
were reasonably consistent with USPSTF recommen-
dations and freely available for public use. For prostate 
cancer screening, we chose a composite of 2 paper-
based decision aids developed by a multidisciplinary 
prostate cancer work group for the Massachusetts 
Department of Public Health for dissemination to 
primary care clinicians for use with men in Massachu-
setts.37,38 In a small pilot test, the decision aids were 
well received by patients and clinicians. For mammog-
raphy, we used a paper-based Summary for Patients 
from the American College of Physicians that outlined 
the 2007 guidelines for mammography screening in 
women aged 40 to 49 years.39
Participant Recruitment
Men aged 50 to 74 years without a history of pros-
tate cancer and women aged 40 to 49 years without a 
history of breast cancer who spoke English or Span-
ish were eligible to participate. We recruited a con-
venience sample using a broad outreach approach, 
including mailings to potentially eligible participants 
attending primary care clinics identified from hospital 
and community health center administrative data, signs 
placed in the academic medical center, outreach to 
persons who had indicated interest in participating in 
research studies to the UMass Center for Clinical and 
Translational Science, outreach to community contacts 
by study members from the Central Massachusetts 
Area Health Education Center, and ads posted on 
Craigslist. Our goal was to recruit a sample with as 
much racial, ethnic, linguistic, and socioeconomic vari-
ation as possible with our available resources. Partici-
pants were informed they would be paid $40 for up to 
2 hours of their time. Interested eligible persons were 
scheduled to come in for a study visit with a bilingual 
community health worker.
Conduct of Study Sessions
All participants received both interventions. For the 
following reasons they were randomly assigned to see 
either our video intervention or the printed decision 
aid first: (1) comments in our phase 2 focus groups 
about the value of hearing the information more than 
once made us suspect we might see greater effects 
from multiple exposures; (2) as a formative study, we 
wanted to compare information from participants 
about the 2 types of interventions; and (3) we wanted 
to maximize the information we could obtain from 
each participant, knowing our resources were limited.
Study data were collected and managed using elec-
tronic data capture (REDCap) research tools40 hosted 
at the University of Massachusetts Medical School 
(UMMS). Randomization was carried out via REDCap 
with concealed allocation, stratified by sex and lan-
guage spoken. Participants responded to survey ques-
tions in English or Spanish using a touchscreen tablet 
that directly entered the data into REDCap; a com-
munity health worker provided assistance as needed. 
After answering questions about demographics, family 
history, and experience with the screening test, par-
ticipants were asked to indicate whether they wanted 
the test (yes, unsure, no), felt getting the test was right 
for them, and expected to discuss screening with their 
physician in the coming year (5-point Likert scales from 
“definitely yes” to “definitely no”). The low-literacy ver-
sion of the Decisional Conflict Scale41,42 was used to 
measure 4 aspects of decisional conflict—uncertainty, 
feeling informed, clarity about personal values, and 
feeling supported in making the decision—with higher 
scores reflecting greater conflict.41 We also asked them 
their opinion on the balance of benefits and harms of 
the screening test (based on a 5-point Likert scale) 
and to indicate how much the women thought regular 
screening reduced a person’s risk of dying of cancer 
(less than 25%, 25% to 49%, 50% to 75%, more than 
75%, or absolutely no idea). Women were asked how 
often a woman should get mammograms once she 
started (every 1, 2, or 3 years, or not sure). Participants 
were then shown the intervention they had been ran-
domized to see first and asked again to complete the 
Decisional Conflict Scale and the questions about their 
screening intentions and perceived benefits and harms. 
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The community health worker offered to clarify any 
issues within their scope of training. Participants were 
shown the second intervention and asked to answer 
questions including those listed above.
This project was approved by the University of Mas-
sachusetts Medical School Institutional Review Board.
Analyses
Statistical analyses were conducted using SAS 9.2 (SAS 
Institute, Inc). Nonparametric tests were used to assess 
significance of responses to questions with yes, unsure, 
no and Likert-scale scores. Changes on the Decisional 
Conflict Scale responses were assessed using t tests. 
We compared changes in screening attitudes and inten-
tions after seeing each intervention, suspecting from 
previous feedback that attitudes might change progres-
sively after seeing each intervention.
RESULTS
As shown in Table 1, 27 men and 35 women partici-
pated. Most were non-Hispanic white, and nearly 
90% had some education beyond high school. About 
one-fourth of women were Spanish-speaking Latinas, 
whereas only 1 man was a Spanish-speaking Latino.
As displayed in Figures 1 and 2, preferences for 
both prostate cancer screening and mammography 
changed significantly after viewing the video presenta-
tions but not after viewing the print (control) decision 
aid. For men, preferences changed primarily from 
wanting to not wanting screening, whereas for women 
the change was more balanced between being unsure 
and not wanting screening. Because the order of the 
information given had no effect, we presented the 
analyses of changes after seeing each type of interven-
tion, ignoring order. We found significant changes in 
participants’ desire for both tests, feeling the test was 
right for them, and perceptions of the balance of ben-
efits and harms. There was also a smaller, but statisti-
cally significant, change in men’s perceptions of the 
balance of benefits and harms after viewing the print 
comparator (Table 2). Although our interventions were 
intended for shared decision making, we found they 
resulted in a significant decrease in men’s intentions to 
discuss prostate cancer screening with their physicians; 
women’s intentions trended in the same direction, 
though they were not significant at the P <.05 level.
Desired frequency of mammography screening 
also changed after seeing the interventions. At entry, 
54% of women reported that women should get annual 
mammograms once they started, and 34% indicated 
it should be biennial. This frequency changed to 
14% annually and 60% biennially after viewing both 
interventions. Endorsement of biennial mammograms 
increased minimally (6%) after seeing the paper deci-
sion aid and more (20%) after our seeing our narrated 
video intervention, but this difference was not statisti-
cally significant.
Decisional Conflict Scale scores decreased substan-
tially and progressively, and they were also not statisti-
cally significantly related to which intervention was 
received first. On a scale ranging from 0 (no conflict) 
to 100 (maximal conflict), scores for men decreased 
from a mean of 57 to 15 after seeing their first inter-
vention and further decreased to a mean of 8 after see-
ing the second. For women, scores decreased from 32 
to 18 to 13, respectively.
DISCUSSION
Our interventions, designed to help viewers trust and 
accept the recommendations from the USPSTF on 
prostate cancer screening for men and screening mam-
mography for women aged 40 to 49 years clearly influ-
enced a number of participants to reconsider whether 
they wanted screening and changed the reported 
preferences of statistically significant proportions of 
our participants. This outcome is notably different 
from those reported for the use of many decision aids, 
including a recently published randomized controlled 
trial comparing 4 print formats for presenting informa-
tion about 3 low-value screening tests, including the 
PSA test43; a recent evaluation of a decision aid for 
mammography for women in their forties that reported 
a significant decrease in decisional conflict, but no 
significant change in screening intentions44; and the 
Table 1. Participant Demographics
Characteristic
Men 
(n = 27)
Women 
(n = 35)
Mean age, y 58 46
Race, %   
White 85 60
Black 4 3
Asian 0 6
Other, unknowna 11 31
Hispanic ethnicity, % 11 34
Education, %   
≤High school graduate 12 11
Some college or college graduate 35 49
≥4 Years of college 54 40
Previously screened for prostate/breast 
cancer, %
46 91
Previous abnormal prostate/breast cancer 
screening result, %
11 37
Previous prostate/breast biopsy, % 4 9
a Almost all Hispanic participants left the race options blank, as they did not 
identify with race as a construct.
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Cochrane review of decision aids, which found vari-
able effects on choices, including mixed effects for PSA 
decision aids.19
We believe there are several reasons why, in our 
study, men were more likely than women to change 
from desiring to rejecting screening and women were 
more likely to end up uncertain. Major harms associ-
ated with prostate cancer screening (eg, impotence and 
incontinence) are easily understood and highly unde-
sirable, whereas some harms associated with mammog-
Figure 1. Expressed preferences for prostate-specific antigen testing after seeing video, then paper, or vice versa 
(total n = 27 men aged 50-74 years).
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Figure 2. Expressed preferences for mammography testing after seeing video, then paper, or vice versa (total 
n = 35 women aged 40-49 years).
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
Baseline
(video 
1st group)
After 
video 
After 
paper 
Baseline 
(paper 1st 
group)
After 
paper 
After 
video 
No Unsure 
Pe
rc
en
ta
g
e
Yes 
C ANCER SCREENING DECISIONS
ANNALS OF FAMILY MEDICINE ✦ WWW.ANNFAMMED.ORG ✦ VOL. 15, NO. 1 ✦ JANUARY/FEBRUARY 2017
52
ANNALS OF FAMILY MEDICINE ✦ WWW.ANNFAMMED.ORG ✦ VOL. 15, NO. 1 ✦ JANUARY/FEBRUARY 2017
53
raphy are less clear (eg, anxiety) or subtle and poorly 
understood (eg, overdiagnosis and overtreatment). 
Second, the evidence we presented indicated that pros-
tate cancer screening might provide no benefit, sav-
ing 0 to 1 life per 1,000 men screened over 10 years, 
whereas mammography evidence indicated a modest 
mortality reduction of 1 life saved for every 2,000 
women screened over 10 years. Third, our qualitative 
work found that women have been heavily socialized 
to value mammography, which was uncommon for PSA 
screening. Finally, the USPSTF recommendation is 
against prostate cancer screening; for mammography 
the recommendation is to make an informed choice, 
and women accepting the USPSTF’s recommendation 
might appropriately end up being uncertain, with fewer 
expected to decide against screening.
In developing this project, given the generally lim-
ited effects of knowledge on behavior, we had expected 
to focus on crafting persuasive messages rather than 
offering substantial amounts of the data about the tests. 
Our focus group work, however, led us to believe we 
needed to present the key data. We found that if we 
could get people to consider the USPSTF recommen-
dations, they wanted to know the data were available 
on which the recommendations were based, even if it 
was hard to understand. For the USPSTF mammogra-
phy recommendation, where patients are encouraged to 
make a personal, informed decision rather than a spe-
cific choice, we are unclear what the appropriate next 
step should be for those who, understanding the issues, 
find themselves uncertain about what to do. Providing 
additional resources may help some patients, but find-
ing resources for unbiased, balanced, and sufficiently 
complete information is problematic. Choosing what 
information to present, the order and style of presenta-
tion, and the amount of detail is an editorial choice 
that reflects the views of the developers. The more 
controversial the decision, the more difficult and impor-
tant such choices will be. Carefully trained navigators 
might be able to help uncertain patients make a choice 
without injecting bias, but sustainable funding for such 
efforts outside a few special cases seems unlikely. Our 
findings also highlight that better informed patients 
may be less likely to want to share decision making 
with their clinicians.
Of note, most women expressed a preference for 
biennial rather than annual screening after seeing both 
interventions. If such a decision were durable and acted 
upon, it would substantially reduce the harms and costs 
of mammography with a minimal decrease in benefit.45
We found similarly substantial reductions in deci-
sional conflict with our narrated, persuasive video 
interventions and the print decision-aid interventions, 
whereas only our video interventions had any effect on 
preferences. For mammography, we had hypothesized 
that a greater understanding of the issues might lead to 
greater decisional conflict, but we did not observe this 
outcome. Our findings should lead to careful thought 
about the role of decisional conflict in assessing overall 
decisional quality, because they suggest that a reduc-
tion in decisional conflict may be more reflective of 
going through the process of making or confirming a 
previous decision than of how well information was 
really understood and utilized. 
Our study has a number of limitations. First, we 
measured a short-term change in attitudes, but we do 
not know whether this change will translate into action. 
Second, the print interventions we used for compari-
Table 2. Changes in Screening Attitudes Toward Cancer Screening
Measure
After Printed  
(Control) Intervention 
Mean Change  
(P Value)a
After Video  
Intervention 
Mean Change  
(P Value)a
Video vs Print 
Difference  
Mean Change  
(P Value)a
PSA screening    
Want PSA (yes = 2, unsure = 1, no = 0) 0.0 (>.99) –0.93 (<.001) –0.88 (<.001)
PSA right for meb 0.0 (>.99) –1.6 (<.001) –1.6 (<.001)
PSA harm-benefit balanceb –0.53 (.01) –1.9 (<.001) –1.3 (.007)
Intend to discuss PSA with physicianb 0.12 (.38) –0.44 (.03) –0.58 (.003)
Mammography screening    
Want mammography (yes = 2, unsure = 1, no = 0) –0.06 (.75) –0.50 (<.001) –0.44 (.01)
Mammography right for meb 0.06 (.82) –0.77 (<.001) –0.83 (.002)
Mammography harm-benefit balanceb –0.14 (.38) –0.65 (<.001) –0.50 (.046)
Intend to discuss mammography with physicianb 0.0 (>.99) –0.29 (.07) –0.29 (.17)
PSA = prostate-specific antigen. 
Note: Interventions were presented to participants randomly.
a Wilcoxon signed rank tests used to assess significance.
b Score based on 5-point Likert scale, where 1= definitely yes, to 5 = definitely no.
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son cannot be assumed to be representative of all print 
decision aids intended to inform but not designed to 
be persuasive interventions. We believed it was impor-
tant to present for comparison nonproprietary decision 
aids that did not conflict with the evidence summaries 
produced for the USPSTF. Our video interventions dif-
fered in many ways from the paper decision aids used 
for comparison besides their persuasive aims. The paper 
PSA decision aid encouraged making a choice based 
on personal values and consulting one’s physician, so 
any induced change would be expected to be smaller. 
Our narrated video slide shows with a story line were 
more engaging than the print presentations. Our video 
interventions ran 13 to 23 minutes, substantially longer 
than participants spent with the print decision aids 
and provided more detailed information, because our 
formative work indicated patients wanted to see the evi-
dence when considering the counterintuitive USPSTF 
recommendations. It is possible that narrated presenta-
tions of similar length and detail but not designed to 
encourage viewers to trust and accept a specific recom-
mendation would have had similar effects. Based on our 
experiences in phase 1 of this project, we think this is 
unlikely. Third, we chose to use the low-literacy ver-
sion of the Decisional Conflict Scale, because we were 
expecting many participants to have limited literacy. 
The article describing the low-literacy version of the 
Decisional Conflict Scale raised some questions about 
distinctness and validity of some subscales, however, so 
our findings could be affected by specific characteristics 
of the low-literacy Decisional Conflict Scale. Finally, 
we tested our interventions with small, convenience 
samples of men and women in one city in central Mas-
sachusetts. Generalizability of our findings to other 
populations needs to be evaluated in future studies.
Given our results, we believe that findings from 
our prior qualitative work, along with guidance from 
behavioral science and marketing research, led to the 
success of our video interventions. If our video inter-
vention findings are replicated in other populations, 
they could serve as a template for the development of 
persuasive interventions when targeting other contro-
versial recommendations and low-value procedures. 
We offer the following points when developing such 
interventions:
1. Begin by asking people to think about the key 
questions without directly confronting their existing 
beliefs to set the stage for reconsideration while mini-
mizing the risk of a defensive response.
2. Follow with describing harms and making 
explicit that benefits are smaller than most believe.
3. Offer difficult information more than once, with 
increasing detail, to allow viewers to grasp the overall 
message before they try to understand the finer details.
4. Portray a trusted professional as the source of 
information to encourage narrative engagement and 
evoke credibility.
A key question is whether interventions such as 
ours will lead to changes in behavior. An important 
next step is testing such interventions in pragmatic 
clinical trials to evaluate them in clinical practice.
We are aware that a persuasive approach is likely to 
arouse controversy, because persuasion is sometimes 
used to convince people to make choices not to their 
advantage. The reality, however, is that persuasive mes-
sages have been widely disseminated for many years, 
with the result that few patients are starting from a 
neutral position. We believe that it is important to 
accept that, in the face of advocacy messages and the 
power of anecdotes, persuasive counter-messaging may 
be both needed and warranted to convince consumers 
to be receptive to evidence and evidence-based recom-
mendations that may run counter to existing beliefs 
and help them make more evidence-based choices.
To read or post commentaries in response to this article, see it 
online at http://www.annfammed.org/content/15/1/48.
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making; mammography; prostate cancer; persuasive interventions
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